Health Products Act 2007 |
Health Products (Cell, Tissue and Gene Therapy Products) (Amendment) Regulations 2023 |
|
Citation and commencement |
Amendment of regulation 2 |
2. In the Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021 (G.N. No. S 104/2021) (called in these Regulations the principal Regulations), in regulation 2(1) —
|
Amendment of regulation 9 |
3. In the principal Regulations, in regulation 9(a) —
|
Replacement of regulation 12 |
4. In the principal Regulations, replace regulation 12 with —
|
Amendment of regulation 15 |
5. In the principal Regulations, in regulation 15(1), replace sub‑paragraphs (b) to (e) with —
|
Amendment of regulation 16 |
6. In the principal Regulations, in regulation 16(1), after “(e)”, insert “, (ea), (eb), (ec)”. |
Amendment of regulation 18 |
7. In the principal Regulations, in regulation 18 —
|
Amendment of regulation 21 |
8. In the principal Regulations, in regulation 21, replace paragraph (b) with —
|
Amendment of regulation 26 |
9. In the principal Regulations, in regulation 26(1), replace sub‑paragraph (b) with —
|
Amendment of regulation 33 |
10. In the principal Regulations, in regulation 33(1)(b), replace “(b) or (e)” with “(b), (c), (ea), (eb) or (ec)”. |
Amendment of regulation 34 |
11. In the principal Regulations, in regulation 34 —
|
Amendment of regulation 40 |
12. In the principal Regulations, in regulation 40(a), replace sub‑paragraph (iii) with —
|
Miscellaneous amendments |
13. In the principal Regulations, in regulation 2(1), in the definition of “qualified practitioner” —
|
Chairperson, Health Sciences Authority, Singapore. |
[401:04/01-000.; MH 78:44/1; AG/LEGIS/SL/122D/2020/13 Vol. 1] |
(To be presented to Parliament under section 72(5) of the Health Products Act 2007). |